Advertisement
Advertisement
LYEL
Lyell Immunopharma, Inc. Common Stock
13.00
USDSponsored
+0.37
+2.93%
Jun 24, 16:00 UTC -4
Closed
After-Market
13.00
0.00
0.00%
LYEL Earnings Reports
Positive Surprise Ratio
LYEL beat 15 of 20 last estimates.
75%
Next Report
Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$4.69K
/-$2.07
Implied change from Q1 26 (Revenue/ EPS)
+134.60%
/+88.18%
Implied change from Q2 25 (Revenue/ EPS)
-41.35%
/-28.37%
Lyell Immunopharma, Inc. Common Stock earnings per share and revenue
On May 06, 2026, LYEL reported earnings of -1.10 USD per share (EPS) for Q1 26, beating the estimate of -2.41 USD, resulting in a 54.40% surprise. Revenue reached 2.00 thousand, compared to an expected 4.49 thousand, with a -55.44% difference. The market reacted with a -3.79% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -2.07 USD, with revenue projected to reach 4.69 thousand USD, implying an increase of 88.18% EPS, and increase of 134.60% in Revenue from the last quarter.
FAQ
What were Lyell Immunopharma, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Lyell Immunopharma, Inc. Common Stock reported EPS of -$1.10, beating estimates by 54.4%, and revenue of $2.00K, -55.44% below expectations.
How did the market react to Lyell Immunopharma, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -3.79%, changed from $20.85 before the earnings release to $20.06 the day after.
When is Lyell Immunopharma, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for Lyell Immunopharma, Inc. Common Stock's next earnings report?
Based on --
analysts, Lyell Immunopharma, Inc. Common Stock is expected to report EPS of -$2.07 and revenue of $4.69K for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement